This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, M. H. Articles by Chae, C.-B. Search for Related Content PubMed PubMed Citation Articles by Lee, M. H. Articles by Chae, C.-B.

Expression of the Functional Extracellular Domain of Human Thyrotropin Receptor Using a Vaccinia Virus System: Its Purification and Analysis of Autoantibody Binding¹

Department of Life Science and Biotechnology Research Center, Pohang University of Science and Technology, Pohang 790–784; and the Department of Internal Medicine, Seoul National University College of Medicine (B.Y.C.), Seoul 110–744, Korea

Address all correspondence and requests for reprints to: Dr. Chi-Bom Chae, Department of Life Science and Biotechnology Research Center, Pohang University of Science and Technology, Pohang 790–784, Korea. E-mail: cbchae{at}postech.ac.kr

We produced substantial amount of the extracellular domain of the human TSH receptor (TSHRE) that has a tag of six histidines at C-terminus as a soluble form in the human cell line HeLa using a vaccinia virus system. By sequential nickel-chelating and lentil lectin column chromatography, TSHRE was purified to about 70% purity, with the recovery of around 0.1–0.2 mg TSHRE/L culture (5 x 10⁸ cells/liter culture). The purified TSHRE interacted with TSH as well as Graves’ autoantibodies to TSHR. However, the affinity of TSHRE for TSH was much lower than that of intact TSHR. The IC₅₀ value for inhibition of TSH-dependent cAMP synthesis by TSHRE was about 10^-8 mol/L. Most importantly, the purified TSHRE inhibited the binding of the IgG of Graves’ patients to thyroid membrane. About 1 µg/mL (2 x 10^-8 mol/L) TSHRE neutralized most of the autoantibody activity of patients’ sera tested in the TSH binding inhibitory immunoglobulin (TBII) assay. Moreover, this protein neutralized thyroid stimulatory antibody-induced cAMP synthesis with an IC₅₀ of 1 x 10^-9 mol/L and completely at 0.5–1 µg/mL (1–2 x 10^-8 mol/L). In the simple enzyme-linked immunosorbent assay, the TSHRE immobilized on the wells coated with nickel showed significantly higher binding with the IgGs from Graves’ patients than in those from normal individuals. This autoantibody-reactive TSHRE will be useful for further studies on the diagnosis, pathogenesis, and the development of therapy of Graves’ disease.

This article has been cited by other articles:

				F. Latrofa, G. D. Chazenbalk, P. Pichurin, C.-R. Chen, S. M. McLachlan, and B. Rapoport Affinity-Enrichment of Thyrotropin Receptor Autoantibodies from Graves' Patients and Normal Individuals Provides Insight into Their Properties and Possible Origin from Natural Antibodies J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4734 - 4745. [Abstract] [Full Text] [PDF]

				J. Van Sande, M. J. Costa, C. Massart, S. Swillens, S. Costagliola, J. Orgiazzi, and J. E. Dumont Kinetics of Thyrotropin-Stimulating Hormone (TSH) and Thyroid-Stimulating Antibody Binding and Action on the TSH Receptor in Intact TSH Receptor-Expressing CHO Cells J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5366 - 5374. [Abstract] [Full Text] [PDF]

				C. H. Na, M. H. Lee, B. Y. Cho, and C.-B. Chae A Method for Identification of the Peptides That Bind to a Clone of Thyroid-Stimulating Antibodies in the Serum of Graves' Disease Patients J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1570 - 1576. [Abstract] [Full Text] [PDF]

				G. B. Fralish, P. Narayan, and D. Puett High-Level Expression of a Functional Single-Chain Human Chorionic Gonadotropin-Luteinizing Hormone Receptor Ectodomain Complex in Insect Cells Endocrinology, April 1, 2001; 142(4): 1517 - 1524. [Abstract] [Full Text]